AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 287: R274-R275, 2004; doi:10.1152/ajpregu.00212.2004
0363-6119/04 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romanovsky, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romanovsky, A. A.

EDITORIAL FOCUS

Anorexia: the toll for lipopolysaccharide recognition

Andrej A. Romanovsky

Systemic Inflammation Laboratory, Trauma Research, St. Joseph's Hospital, Phoenix, Arizona 85013

THE REVIEWS OF Hart (13) and Kent et al. (20) have drawn attention to the so-called sickness syndrome, a suite of autonomic and behavioral manifestations (sickness symptoms or responses) of systemic inflammation. The syndrome unites sickness responses (e.g., fever, hypothermia, hyperalgesia and/or allodynia, hypoalgesia, sleep, and anorexia) that have different latencies and durations and follow one another as the disease progresses (32, 33). Although sickness responses, when unchecked, can have pathological consequences, they are generally believed to be adaptive (13, 20, 33). The sickness syndrome is often induced in the laboratory by injecting animals with bacterial LPS. Recent articles published by the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology are dedicated to mechanisms of several sickness symptoms occurring in response to LPS: fever (3, 8, 9, 12, 16–19, 23, 26, 35), activation of the hypothalamo-pituitary-adrenal axis (10, 19), and anorexia (24, 39). The article by von Meyenburg et al. (39) in the current issue examines whether two proteins involved in LPS signaling, the glycoprotein CD14 and Toll-like receptor 4 (TLR4), are required for LPS-induced anorexia. These two proteins—along with myeloid differentiation protein-2 and LPS-binding protein—are considered the key molecules for LPS recognition. Cellular TLR4 recognizes LPS and responds to it only after LPS interacts with CD14 (1, 27, 31; for additional references, see Ref. 39). By studying food consumption in genetically modified mice, von Meyenburg et al. (39) showed that the anorectic response to LPS is reduced in both CD14 knockouts and TLR4-deficient mutants, thus indicating that CD14 and TLR4 are required for the development of LPS-induced anorexia.

This observation is important because anorexia was viewed for many years as the "black sheep" among the responses to LPS. Early findings by J. H. Brobeck and others showing that body temperature affects food consumption (e.g., Ref. 2) led to the belief that infection-associated or LPS-induced anorexia is not an independent response but that it occurs secondarily to fever, simply reflecting the dependence of food intake on body temperature. This belief was later disproved by showing that LPS-induced anorexia is unrelated to body temperature (22, 25). There was also reason to suspect that LPS causes anorexia via an atypical signaling pathway specific for this response. Administration of LPS results in tolerance, a state in which responses to subsequently administered LPS are decreased (for review, see Refs. 4, 5). This is true in regards to the febrile, hypotensive, antidiuretic, hyperglycemic, leukopenic, and many other responses. As an exception to this rule, the anorexic response was found to occur in tolerant rats in a study by O'Reilly et al. (28), although the same animals developed no febrile response. However, this unusual result was not confirmed by subsequent studies (7, 21) and was thought to reflect a methodological peculiarity (21).

The article of von Meyenburg et al. (39) also reports an interesting observation that the absence of another Toll-like receptor, TLR2, does not affect LPS anorexia. This observation is important, because, until recently, TLR2 was thought by some to recognize LPS (37) and mediate LPS-induced sickness symptoms such as fever (6). However, Hirschfeld et al. (14) demonstrated that it is not LPS per se but rather a highly bioactive lipopeptide contaminant of LPS preparations ("endotoxin protein") that signals through TLR2. The same receptor, TLR2, plays a major role in recognition of cell wall constituents of gram-positive bacteria, e.g., muramyl dipeptide (36, 38). In agreement with such a role, von Meyenburg et al. (39) showed that muramyl dipeptide-induced anorexia is attenuated in TLR2-knockout mice.

In addition to the molecules mentioned above, LPS recognition may involve other receptors, most notably CD11/CD18 {beta}2-integrin (30) and cell-surface proteins known as scavenger receptors (29). Gioannini et al. (11) list several more examples of proteins that may participate in cellular activation by LPS depending on specific structural features of particular LPS species, the host cell types examined, and the response studied. It is possible, therefore, that some of these molecules can also contribute to triggering the sickness syndrome, and von Meyenburg et al. (39) acknowledge such a possibility. This possibility seems likely because the same dose of LPS can cause different responses in the same species depending on the experimental conditions, e.g., rats respond to LPS with fever at a neutral ambient temperature but develop hypothermia (at least transient) at a subneutral temperature (17, 34). Such duality of LPS action has been speculated (15) to reflect different distribution of the blood in the body at different ambient temperatures and, consequently, different distribution of LPS and its recognition by different cells possibly via different receptors. A better understanding of the recognition systems and mechanisms of their coupling with different sickness responses may pave the road for development of new therapeutic approaches. The article by von Meyenburg et al. (39) is an important pavestone on this road, or should I say toll road?

FOOTNOTES  

Address for reprint requests and other correspondence: A. A. Romanovsky, Trauma Research, St. Joseph's Hospital, 350 W. Thomas Rd., Phoenix, AZ 85013 (E-mail: aromano{at}chw.edu).

REFERENCES

  1. Beutler B and Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3: 169–176, 2003.[CrossRef][Web of Science][Medline]
  2. Brobeck JR. Food and temperature. Recent Prog Horm Res 16: 439–466, 1960.[Web of Science][Medline]
  3. Buchanan JB, Peloso E, and Satinoff E. Thermoregulatory and metabolic changes during fever in young and old rats. Am J Physiol Regul Integr Comp Physiol 285: R1165–R1169, 2003.[Abstract/Free Full Text]
  4. Cavaillon JM, Adrie C, Fitting C, and Adib-Conquy M. Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res 9: 101–107, 2003.[CrossRef][Web of Science]
  5. Cross AS. Endotoxin tolerance—current concepts in historical perspective. J Endotoxin Res 8: 83–98, 2002.[CrossRef][Web of Science]
  6. Dinarello CA, Gatti S, and Bartfai T. Fever: links with an ancient receptor. Curr Biol 9: R147–R150, 1999.[CrossRef][Web of Science][Medline]
  7. Faggioni R, Fantuzzi G, Villa P, Buurman W, van Tits LJ, and Ghezzi P. Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect Immun 63: 1473–1477, 1995.[Abstract]
  8. Feleder C, Li Z, Perlik V, Evans A, and Blatteis CM. The spleen modulates the febrile response of guinea pigs to LPS. Am J Physiol Regul Integr Comp Physiol 284: R1466–R1476, 2003.[Abstract/Free Full Text]
  9. Gatti S, Beck J, Fantuzzi G, Bartfai T, and Dinarello CA. Effect of interleukin-18 on mouse core body temperature. Am J Physiol Regul Integr Comp Physiol 282: R702–R709, 2002.[Abstract/Free Full Text]
  10. Gayle DA, Beloosesky R, Desai M, Amidi F, Nunez SE, and Ross MG. Maternal lipopolysaccharide induces cytokines in the amniotic fluid and corticotropin releasing hormone in the fetal rat brain. Am J Physiol Regul Integr Comp Physiol 286: R1024–R1029, 2004. First published February 2004, 10.1152/ajpregu.00664.2003.[Abstract/Free Full Text]
  11. Gioannini TL, Teghanemt A, Zarember KA, and Weiss JP. Regulation of interactions of endotoxin with host cells. J Endotoxin Res 9: 401–408, 2003.[CrossRef][Web of Science]
  12. Gourine AV, Gourine VN, Tesfaigzi Y, Caluwaerts N, Van Leuven F, and Kluger MJ. Role of {alpha}2-macroglobulin in fever and cytokine responses induced by lipopolysaccharide in mice. Am J Physiol Regul Integr Comp Physiol 283: R218–R226, 2002.[Abstract/Free Full Text]
  13. Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12: 123–137, 1988.[CrossRef][Web of Science][Medline]
  14. Hirschfeld M, Ma Y, Weis JH, Vogel SN, and Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165: 618–622, 2000.[Abstract/Free Full Text]
  15. Ivanov AI, Patel S, Kulchitsky VA, and Romanovsky AA. Platelet-activating factor: a previously unrecognized mediator of fever. J Physiol 553: 221–228, 2003.[Abstract/Free Full Text]
  16. Ivanov AI, Pero RS, Scheck AC, and Romanovsky AA. Prostaglandin E2-synthesizing enzymes in fever: differential transcriptional regulation. Am J Physiol Regul Integr Comp Physiol 283: R1104–R1117, 2002.[Abstract/Free Full Text]
  17. Ivanov AI and Romanovsky AA. Fever responses of Zucker rats with and without fatty mutation of the leptin receptor. Am J Physiol Regul Integr Comp Physiol 282: R311–R316, 2002.[Abstract/Free Full Text]
  18. Ivanov AI, Scheck AC, and Romanovsky AA. Expression of genes controlling transport and catabolism of prostaglandin E2 in lipopolysaccharide fever. Am J Physiol Regul Integr Comp Physiol 284: R698–R706, 2003.[Abstract/Free Full Text]
  19. Johnson JD, O'Connor KA, Hansen MK, Watkins LR, and Maier SF. Effects of prior stress on LPS-induced cytokine and sickness responses. Am J Physiol Regul Integr Comp Physiol 284: R422–R432, 2003.[Abstract/Free Full Text]
  20. Kent S, Bluthé RM, Kelly KW, and Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13: 24–28, 1992.[CrossRef][Medline]
  21. Langhans W, Balkowski G, and Savoldelli D. Differential feeding responses to bacterial lipopolysaccharide and muramyl dipeptide. Am J Physiol Regul Integr Comp Physiol 261: R659–R664, 1991.[Abstract/Free Full Text]
  22. Larson SJ, Collins SM, and Weingarten HP. Dissociation of temperature changes and anorexia after experimental colitis and LPS administration in rats. Am J Physiol Regul Integr Comp Physiol 271: R967–R972, 1996.[Abstract/Free Full Text]
  23. Ledeboer A, Binnekade R, Breve JJ, Bol JG, Tilders FJ, and Van Dam AM. Site-specific modulation of LPS-induced fever and interleukin-1{beta} expression in rats by interleukin-10. Am J Physiol Regul Integr Comp Physiol 282: R1762–R1772, 2002.[Abstract/Free Full Text]
  24. Lugarini F, Hrupka BJ, Schwartz GJ, Plata-Salaman CR, and Langhans W. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am J Physiol Regul Integr Comp Physiol 283: R862–R868, 2002.[Abstract/Free Full Text]
  25. McCarthy DO, Kluger MJ, and Vander AJ. The role of fever in appetite suppression after endotoxin administration. Am J Clin Nutr 40: 310–316, 1984.[Abstract/Free Full Text]
  26. Miyoshi M, Nagata K, Imoto T, Goto O, Ishida A, and Watanabe T. ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats. Am J Physiol Regul Integr Comp Physiol 284: R1092–R1097, 2003.[Abstract/Free Full Text]
  27. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, and Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immun 3: 667–672, 2002.
  28. O'Reilly B, Vander AJ, and Kluger MJ. Effects of chronic infusion of lipopolysaccharide on food intake and body temperature of the rat. Physiol Behav 42: 287–291, 1988.[CrossRef][Medline]
  29. Pearson AM. Scavenger receptors in innate immunity. Curr Opin Immunol 8: 20–28, 1996.[CrossRef][Web of Science][Medline]
  30. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM, and Vogel SN. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166: 574–581, 2001.[Abstract/Free Full Text]
  31. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085–2088, 1998.[Abstract/Free Full Text]
  32. Romanovsky AA. Signaling the brain in the early sickness syndrome: are sensory nerves involved? Front Biosci 9: 494–504, 2004.[Web of Science][Medline]
  33. Romanovsky AA, Kulchitsky VA, Akulich NV, Koulchitsky SV, Simons CT, Sessler DI, and Gourine VN. First and second phases of biphasic fever: two sequential stages of the sickness syndrome? Am J Physiol Regul Integr Comp Physiol 271: R244–R253, 1996.[Abstract/Free Full Text]
  34. Romanovsky AA, Simons CT, Székely M, and Kulchitsky VA. The vagus nerve in the thermoregulatory response to systemic inflammation. Am J Physiol Regul Integr Comp Physiol 273: R407–R413, 1997.[Abstract/Free Full Text]
  35. Sinha PS, Schiöth HB, and Tatro JB. Activation of central melanocortin-4 receptor suppresses lipopolysaccharide-induced fever in rats. Am J Physiol Regul Integr Comp Physiol 284: R1595–R1603, 2003.[Abstract/Free Full Text]
  36. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, and Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443–451, 1999.[CrossRef][Web of Science][Medline]
  37. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, and Godowski PJ. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284–288, 1998.[CrossRef][Medline]
  38. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, and Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163: 1–5, 1999.[Abstract/Free Full Text]
  39. Von Meyenburg C, Hrupka BH, Arsenijevic D, Schwartz GJ, Landmann R, and Langhans W. Role for CD14, TLR2, and TLR4 in bacterial product-induced anorexia. Am J Physiol Regul Integr Comp Physiol 287: R298–R305, 2004.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romanovsky, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romanovsky, A. A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.